VEGI Polyclonal Antibody

The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This protein is abundantly expressed in endothelial cells, but is not expressed in either B or T cells. The expression of this protein is inducible by TNF and IL-1 alpha. This cytokine is a ligand for receptor TNFRSF25 and decoy receptor TNFRSF21/DR6. It can activate NF-kappaB and MAP kinases, and acts as an autocrine factor to induce apoptosis in endothelial cells. This cytokine is also found to inhibit endothelial cell proliferation, and thus may function as an angiogenesis inhibitor. Two transcript variants encoding different isoforms have been found for this gene.

Introducing the VEGI Polyclonal Antibody, a cutting-edge scientific tool designed to revolutionize research in the field of vascular endothelial growth inhibitor (VEGI). This meticulously crafted antibody offers unparalleled specificity and sensitivity, enabling researchers to delve deeper into the intricate mechanisms underlying angiogenesis and inflammation.

The VEGI Polyclonal Antibody boasts a superior affinity for VEGI, a potent endogenous inhibitor of angiogenesis and inflammation. With its exceptional binding capacity, this antibody facilitates the precise detection and quantification of VEGI in various biological samples, including tissues, cells, and bodily fluids.

Crafted with utmost precision, the VEGI Polyclonal Antibody exhibits exceptional reproducibility and reliability, ensuring consistent and accurate results across multiple experiments. Its robust performance is further enhanced by its compatibility with a wide range of experimental techniques, including Western blotting, immunohistochemistry, and immunofluorescence.

This antibody is meticulously manufactured using state-of-the-art techniques, guaranteeing batch-to-batch consistency and minimizing any potential variability. Rigorous quality control measures are implemented throughout the production process to ensure the highest standards of purity, specificity, and functionality.

The VEGI Polyclonal Antibody is supplied in a convenient and user-friendly format, allowing for easy integration into any laboratory workflow. Its long shelf life and stability ensure prolonged usability, making it an ideal choice for both short-term and long-term research projects.

In summary, the VEGI Polyclonal Antibody represents a breakthrough in the field of angiogenesis and inflammation research. With its exceptional specificity, sensitivity, and versatility, this antibody empowers scientists to unravel the complexities of VEGI-mediated processes, paving the way for novel therapeutic interventions and advancements in the field.